Single-source·Jul 17, 2026·2 sources analyzed
FTC Reviews Caremark Insulin Pricing Settlement
The Federal Trade Commission has proposed a consent order regarding a settlement with Caremark. A 30-day public comment period is now open. (sources: www.ftc.gov)
Image: Modern Action subject: Prescription drug prices
Modern Action Briefing
The FTC has reached a settlement with Caremark related to an antitrust case involving insulin pricing. The proposed consent order is now subject to public review.
- The FTC has secured a settlement with Caremark over insulin pricing.
- A proposed consent order has been issued as part of the settlement.
- There is a 30-day public comment period for stakeholders to provide input.
Why it matters
The settlement addresses concerns about pricing practices in the insulin market.
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on Prescription drug prices
See the current decision, choose your position, and send a message through the issue page.
Take action on Prescription drug prices